急性脑梗死是最常见的脑卒中类型,占全部脑卒中的60%~80%。最新的循证医学提示重组组织型纤溶酶原激活剂(reconstive tissueplasminogen activator,rtPA)静脉溶栓治疗是治疗急性脑梗死唯一有效的手段,但需要尽早的溶栓,缩短溶栓前等待时间关系着患者能否纳入时间窗,也影响患者发病早期和三个月时的神经功能恢复。现将我科2010年11月至2012年12月“院内时间窗追踪” Acute cerebral infarction is the most common type of stroke, accounting for 60% to 80% of all strokes. The latest evidence-based medicine suggests that intravenous thrombolysis of reconstive tissueplasminogen activator (rtPA) is the only effective treatment for acute cerebral infarction, but requires early thrombolysis and shortened the waiting time before thrombolysis Whether patients can be included in the time window, but also affect the early onset of patients and neurological recovery at three months. Now our department November 2010 to December 2012 “hospital time window tracking ”